THURSDAY, Oct. 22, 2020 (HealthDay News) — The first company to start a phase 3 trial of a COVID-19 vaccine reached its target of enrolling 30,000 participants, CNN reported Thursday. The company, Moderna, said that all 30,000 have received the first shot, and most have received the second. Half of the participants were given the...